Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Cytoflavin in Acute Traumatic Brain Injury
NCT04631484Phase 3Completed
- Sponsor
- POLYSAN
- Start
- Nov 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Cytoflavin in traumatic brain injury (TBI), sponsored by POLYSAN. Started Nov 2020; status: completed.
02
Drugs
Cytoflavin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04631484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631484.